Bear: In your opinion how do these stunning results, with their NASDAQ listing parent effect our prospects, even with equally great results of our Phase III BetOnMace?

Are we comparing apples and oranges or will we percieved as addressing totally different areas? (Notwithstanding yet to be determined Fabry, Renal, AD etc)

The publicity that VASEPA is currently getting will result in substantial sales in the months and years ahead.

Comments?